Table of Contents
Method of administration
Treatment of patients with chemotherapy induced anaemia:
Dose adjustment to maintain haemoglobin concentrations between 10g/dl 12 g/dl:
Adult surgery patients in an autologous predonation programme:
Adult patients scheduled for major elective orthopaedic surgery:
General
Pure Red Cell Aplasia
Treatment of patients with chemotherapy induced anaemia
Surgery patients in autologous predonation programmes
Patients scheduled for major elective orthopaedic surgery
Chronic renal failure patients
System Organ Class
Frequency
Adverse Drug Reaction
Blood & Lymphatic System Disorders
Uncommon
Thrombocythaemia (cancer patients)
Frequency not known
Erythropoeitin antibody-mediated pure red cell aplasia1
Thrombocythaemia (chronic renal failure patients)
Immune System Disorders
Anaphylactic reaction
Hypersensitivity
Nervous System Disorders
Very common
Headache (cancer patients)
Common
Seizures (chronic renal failure patients)
Headache (chronic renal failure patients)
Cerebral haemorrhage2
Seizures (cancer patients)
Cerebrovascular accident2
Hypertensive encephalopathy
Transient ischaemic attacks
Eye Disorders
Retinal thrombosis
Vascular Disorders
Deep vein thrombosis2 (cancer patients)
Hypertension
Deep vein thrombosis2 (chronic renal failure patients)
Arterial thrombosis
Hypertensive crisis
Respiratory, Thoracic, and Mediastinal Disorders
Pulmonary embolism2 (cancer patients)
Pulmonary embolism2 (chronic renal failure patients)
Gastrointestinal Disorders
Nausea
Diarrhoea (cancer patients)
Vomiting
Diarrhoea (chronic renal failure patients)
Skin and Subcutaneous Tissue Disorders
Rash
Angioneurotic oedema
Urticaria
Musculoskeletal, Connective Tissue, and Bone Disorders
Arthralgia (chronic renal failure patients)
Arthralgia (cancer patients)
Myalgia (cancer patients)
Myalgia (chronic renal failure patients)
Congenital and Familial/Genetic Disorders
Porphyria
General Disorders and Administration Site Conditions
Pyrexia (cancer patients)
Influenza-like illness (chronic renal failure patients)
Influenza-like illness (cancer patients)
Drug ineffective
Peripheral oedema
Pyrexia (chronic renal failure patients)
Injection site reaction
Investigations
Anti-erythropoietin antibody positive1
Injury, Poisoning, and Procedural Complications
Shunt thromboses including dialysis equipment (chronic renal failure patients)
Cancer patients
Surgery patients
I.V. route
S.C. route
Link to this document from your website:http://www.medicines.ie/medicine/12603/SPC/Eprex+40%2c000+IU+ml+solution+for+injection+in+pre-filled+syringe/